Treatment of nodular lymphocyte-predominant Hodgkin lymphoma-"do no harm".
Division of Oncology, Washington University School of Medicine, Siteman Cancer Center, St. Louis, Missouri.
Nancy L
NL
Bartlett
D000970:Antineoplastic Agents / Q000627:therapeutic use*; D006689:Hodgkin Disease / Q000188:drug therapy / Q000378:metabolism / Q000473:pathology; D006801:Humans; D008214:Lymphocytes / Q000378:metabolism / Q000473:pathology
D000970:Antineoplastic Agents